Optimal duration of dual antiplatelet therapy after drug-eluting stent implantation: a randomized, controlled trial.
Lee CW, Ahn JM, Park SJ et al.
KEYWORDS
dAPT duration; coronary artery disease; DES; platelet aggregation; inhibitors; stents; thrombosis